ATYR
Price
$0.43
Change
-$0.00 (-0.00%)
Updated
Sep 11 closing price
Capitalization
41.7M
54 days until earnings call
Intraday BUY SELL Signals
NTLA
Price
$11.74
Change
-$0.19 (-1.59%)
Updated
Sep 11 closing price
Capitalization
1.65B
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ATYR vs NTLA

ATYR vs NTLA Comparison Chart in %
View a ticker or compare two or three
VS
ATYR vs. NTLA commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATYR is a Buy and NTLA is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($1.65B) has a higher market cap than ATYR($41.7M). NTLA YTD gains are higher at: 30.590 vs. ATYR (-45.116). ATYR has higher annual earnings (EBITDA): -62.28M vs. NTLA (-408.24M). NTLA has more cash in the bank: 438M vs. ATYR (57.4M). ATYR has less debt than NTLA: ATYR (11.3M) vs NTLA (73.4M). NTLA has higher revenues than ATYR: NTLA (59.5M) vs ATYR (190K).
ATYRNTLAATYR / NTLA
Capitalization41.7M1.65B3%
EBITDA-62.28M-408.24M15%
Gain YTD-45.11630.590-147%
P/E RatioN/AN/A-
Revenue190K59.5M0%
Total Cash57.4M438M13%
Total Debt11.3M73.4M15%
FUNDAMENTALS RATINGS
ATYR vs NTLA: Fundamental Ratings
ATYR
NTLA
OUTLOOK RATING
1..100
7060
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
25
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
8656
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NTLA's Valuation (25) in the Biotechnology industry is in the same range as ATYR (43) in the null industry. This means that NTLA’s stock grew similarly to ATYR’s over the last 12 months.

NTLA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ATYR (100) in the null industry. This means that NTLA’s stock grew similarly to ATYR’s over the last 12 months.

NTLA's SMR Rating (98) in the Biotechnology industry is in the same range as ATYR (99) in the null industry. This means that NTLA’s stock grew similarly to ATYR’s over the last 12 months.

NTLA's Price Growth Rating (56) in the Biotechnology industry is in the same range as ATYR (86) in the null industry. This means that NTLA’s stock grew similarly to ATYR’s over the last 12 months.

NTLA's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ATYR (100) in the null industry. This means that NTLA’s stock grew similarly to ATYR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATYRNTLA
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
75%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (ATYR: $0.43 vs. NTLA: $11.74)
Brand notoriety: ATYR and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATYR: 184% vs. NTLA: 75%
Market capitalization -- ATYR: $41.7M vs. NTLA: $1.65B
ATYR [@Biotechnology] is valued at $41.7M. NTLA’s [@Biotechnology] market capitalization is $1.65B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATYR’s FA Score shows that 0 FA rating(s) are green while NTLA’s FA Score has 1 green FA rating(s).

  • ATYR’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, NTLA is a better buy in the long-term than ATYR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATYR’s TA Score shows that 4 TA indicator(s) are bullish while NTLA’s TA Score has 3 bullish TA indicator(s).

  • ATYR’s TA Score: 4 bullish, 6 bearish.
  • NTLA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ATYR is a better buy in the short-term than NTLA.

Price Growth

ATYR (@Biotechnology) experienced а -13.57% price change this week, while NTLA (@Biotechnology) price change was -7.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

ATYR is expected to report earnings on Nov 05, 2026.

NTLA is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ATYR
Daily Signal:
Gain/Loss:
NTLA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JSTC22.580.22
+0.98%
Adasina Social Justice All Cp Glbl ETF
RNEM57.200.42
+0.75%
First Trust Emerging Markets Eq Sel ETF
PSL109.950.39
+0.36%
Invesco DW Consumer Staples Momt ETF
MGNR54.27-0.12
-0.22%
American Beacon GLG Natrl Res ETF
JIII48.53-0.11
-0.24%
Janus Henderson Income ETF

ATYR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATYR has been loosely correlated with AMLX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ATYR jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATYR
1D Price
Change %
ATYR100%
-0.49%
AMLX - ATYR
39%
Loosely correlated
-1.46%
IDYA - ATYR
39%
Loosely correlated
+0.37%
SLDB - ATYR
39%
Loosely correlated
-4.08%
NTLA - ATYR
38%
Loosely correlated
-1.59%
OCUL - ATYR
35%
Loosely correlated
-1.22%
More